This site is intended for Healthcare Professionals only

The weight loss medication boom presents an opportunity for pharmacies

Pharmacies can play a unique role to support weight loss journeys, writes Amardeep Bagga

Pharmacies can play a unique role to support weight loss journeys, writes Amardeep Bagga

In recent years, weight loss medications have emerged as methods to aid weight loss.

Obesity is one of the most significant public health challenges facing the UK, with around two-thirds of adults either overweight or living with obesity. These medications might be part of the solution.

A growing market

An estimated 2.4 million people in the UK now receive GLP-1 based medicine

prescriptions each month. When an oral form of weight loss medication launched this summer, the National Pharmacy Association reported that nearly half of the pharmacies it surveyed saw a surge in patient enquiries. Patients are actively seeking this care, and they are walking into pharmacies to find it.

For the first time, obesity and weight loss have become pharmacy's highest value area.

GLP-1 based medicines have gone from representing barely one percent of total pipeline value in 2022 to a quarter of it today.

Supporting patients in their weight loss journey

Community pharmacies are uniquely placed to help patients navigate their weight loss journey. Pharmacies can offer face-to-face consultations to assess whether treatment is appropriate, with ongoing monitoring once it begins. Regular follow-ups can also help sustain progress and address the risk of weight regain when medication is stopped.

Weight loss medications offer an important opportunity for both patients and community pharmacies. GLP-1 based medicines are another way for pharmacies to continue providing the care that patients need.

Amardeep Bagga is a pharmacist and pharmacy consultant with Alphega Pharmacy

Share:

Change privacy settings